Mucoepidermoid carcinoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Badria Munir (talk | contribs) No edit summary |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mucoepidermoid carcinoma}} | {{Mucoepidermoid carcinoma}} | ||
{{CMG}}{{AE}}{{MV}} | {{CMG}}{{AE}}{{Badria}} , {{MV}} | ||
==Overview== | ==Overview== | ||
Line 8: | Line 8: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
* There is no secondary prevention for mucoepidermoid carcinoma. However regular medical screening at periodic intervals with: | |||
** Blood tests | |||
** Radiological scans | |||
** Physical examinations | |||
* Due to its high metastasizing potential and chances of recurrence, often several years of active follow-up and vigilance is recommended. | |||
==References== | ==References== | ||
{{reflist|1}} | {{reflist|1}} | ||
Line 15: | Line 19: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Otolaryngology]] |
Latest revision as of 19:52, 22 January 2019
Mucoepidermoid carcinoma Microchapters |
Differentiating Mucoepidermoid Carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Mucoepidermoid carcinoma secondary prevention On the Web |
American Roentgen Ray Society Images of Mucoepidermoid carcinoma secondary prevention |
Risk calculators and risk factors for Mucoepidermoid carcinoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2] , Maria Fernanda Villarreal, M.D. [3]
Overview
There is no secondary prevention for mucoepidermoid carcinoma.
Secondary Prevention
- There is no secondary prevention for mucoepidermoid carcinoma. However regular medical screening at periodic intervals with:
- Blood tests
- Radiological scans
- Physical examinations
- Due to its high metastasizing potential and chances of recurrence, often several years of active follow-up and vigilance is recommended.